# Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization

> **NCT01037517** · PHASE2 · COMPLETED · sponsor: **CancerCare Manitoba** · enrollment: 52 (actual)

## Conditions studied

- Multiple Myeloma
- Lymphoma

## Interventions

- **DRUG:** Plerixafor
- **OTHER:** Observation: Nonintervention

## Key facts

- **NCT ID:** NCT01037517
- **Lead sponsor:** CancerCare Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037517, "Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01037517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*